Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-28 Purchase | 2023-08-28 4:39 pm | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 14,705 | $6.7976 | $99,959 | 21,688 (Direct) | View |
| 2023-02-08 Sale | 2023-02-10 4:55 pm | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 4,267 | $13.89 | $59,272 | 6,983 (Direct) | View |
| 2020-07-09 Sale | 2020-07-10 4:06 pm | Anika Therapeutics Inc. | ANIK | Loerop James EVP Business Development | 1,244 | $35.15 | $43,727 | 1,756 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-01 Exercise | 2024-02-05 7:29 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 18,750 | $0 | 492,017 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 7:29 pm | N/A 2034-01-31 | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 413,000 | $0 | 492,017 (Direct) | View |
| 2024-02-01 Tax Withholding | 2024-02-05 7:29 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 6,421 | $1.2 | 492,017 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 5:01 pm | N/A 2033-01-31 | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 135,000 | $0 | 180,000 (Direct) | View |
| 2023-02-01 Exercise | 2023-02-03 5:01 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 11,250 | $0 | 180,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-01 4:50 pm | N/A 2032-01-31 | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2021-07-08 Tax Withholding | 2021-07-12 4:15 pm | N/A N/A | Anika Therapeutics Inc. | ANIK | Loerop James EVP Business Development | 731 | $43.24 | 8,592 (Direct) | View |
| 2021-07-08 Exercise | 2021-07-12 4:15 pm | N/A N/A | Anika Therapeutics Inc. | ANIK | Loerop James EVP Business Development | 3,000 | $0 | 8,592 (Direct) | View |
| 2021-03-09 Option Award | 2021-03-11 5:14 pm | N/A N/A | Anika Therapeutics Inc. | ANIK | Loerop James EVP Business Development | 23,507 | $0 | 23,507 (Direct) | View |
| 2021-02-25 Exercise | 2021-03-01 5:19 pm | N/A N/A | Anika Therapeutics Inc. | ANIK | Loerop James EVP Business Development | 1,567 | $0 | 6,456 (Direct) | View |
| 2020-07-08 Option Award | 2020-07-10 4:06 pm | N/A N/A | Anika Therapeutics Inc. | ANIK | Loerop James EVP Business Development | 3,000 | $0 | 1,756 (Direct) | View |
| 2020-02-25 Option Award | 2020-02-27 6:53 pm | N/A N/A | Anika Therapeutics Inc. | ANIK | Loerop James EVP Business Development | 4,700 | $0 | 4,700 (Direct) | View |